Top 10 Evidence-Based Essentials in Family Medicine
-
By
-
Conexiant News Staff
-
May 27, 2026
-
3 min
By
Conexiant News Staff
May 27, 2026
The approval expands subcutaneous use across newly diagnosed and previously treated multiple myeloma.
July 10, 2026
Patients may begin lecanemab-irmb treatment at home through self-administration or administration by a caregiver, according to the FDA.
July 13, 2026
The approval was based on reduced proteinuria, and an ongoing trial is required to determine whether atacicept slows long-term kidney function decline.
July 7, 2026